Pharmacist Evolution in Rheumatology 2023

We are delighted to inform you that the inaugural Pharmacist Evolution in Rheumatology meeting will be taking place on Friday 19th May 2023 at the Leonardo Royal Hotel London Tower Bridge. This meeting is aimed at UK Specialist Rheumatology Pharmacists and is initiated and funded by UCB Pharma Ltd.

Please see the agenda outline; to secure your place at this meeting please register via the button below. I hope that you can join us for what promises to be an informative and interactive meeting.

Please note places at this meeting are limited, your place at this meeting is not confirmed until you receive confirmation from the meeting secretariat. Travel will be paid for by UCB Pharma Ltd in line with the ABPI Code of Practice. The speakers and topics are subject to change and a confirmed agenda will be provided prior to the meeting.

Meeting Co-Chairs:

  • Ms Kalveer Flora
  • Karl Gaffney

Agenda

Friday 19th May 2023

Time Session

09:30-10:00

Registration

10:00-10:15

Welcome and introduction

10:15-10:50

Immunology in a nutshell

10:50-11:10

Workshop: Interpreting images

11:10-11:30

Break

11:30-11:55

Interpreting images: answers and presentation

11:55-12:00

Guidelines updates – session introduction

12:00-12:20

Psoriatic arthritis (PsA)

12:20-12:40

Pregnancy
12:40-13:00

Myositis 

13:00-13:10

Panel Q&A

13:10-13:15

Guidelines in Practice – session introduction

13:15-14:15

Lunch

14:15-15:15

Parallel case study workshops

15:15-15:20

Rapid reviews – session introduction

15:20-15:40

Cutaneous complications of antirheumatic drugs

15:40-16:00

Lupus

16:00-16:35

Vaccine updates

16:35-16:40

Summary and close

This meeting and agenda has been developed in collaboration with a steering committee comprising of:

  • Kalveer Flora
  • Dr James Galloway
  • Hilary McKee
  • Dr Gary Meenagh
  • Aoife Tynan
  • Karl Gaffney

Speakers will be confirmed in due course and sessions are subject to change.

Orbit 360 enabled
Off
On

Register

Places at this meeting cannot be guaranteed. Travel will be booked and paid for by UCB in line with the ABPI Code of Practice.

UCB Pharma Ltd reserves the right to refuse access to those who are unable to confirm their status as a practicing hospital-based HCP.

UCB Pharma Ltd products will be discussed at this meeting.

This promotional meeting is for UK Healthcare Professionals only and is initiated and funded by UCB Pharma Ltd.

Orbit 360 enabled
Off
On

Report adverse events

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk and hpra.ie/homepage/about-us/report-an-issue.

Adverse events should also be reported to UCB Pharma Ltd Email: UCBCares.UK@ucb.com and UCBCares.IE@ucb.com.

Feature requests

Help us to grow our resource the way you want it to grow.

Get in touch now

Date of preparation: March 2023
GB-P-CZ-axSpA-2300013